Ignite Creation Date:
2025-12-24 @ 3:56 PM
Ignite Modification Date:
2025-12-26 @ 6:28 AM
Study NCT ID:
NCT01297192
Status:
COMPLETED
Last Update Posted:
2013-07-29
First Post:
2011-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin Simultaneously
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-03
Start Date Type:
None
Primary Completion Date:
2009-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-07
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-15
First Submit QC Date:
None
Study First Post Date:
2011-02-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-07-25
Last Update Post Date:
2013-07-29
Last Update Post Date Type:
ESTIMATED